Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer

Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer

Introduction: Despite significant advances in systemic anticancer therapy (SACT) for non-small cell lung cancer (NSCLC), many patients still fail to respond to treatment or develop treatment resistance. Albumin, a biomarker of systemic inflammation and malnutrition, predicts survival in many cancers...

Full description

Bibliographic Details
Main Authors: Mark Stares, Amanda Swan, Kirsten Cumming, Tze-En Ding, James Leach, Cory Stratton, Findlay Thomson, Colin Barrie, Kirsty MacLennan, Sorcha Campbell, Tamasin Evans, Aisha Tufail, Stephen Harrow, Melanie MacKean, Iain Phillips
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Nutrition
Subjects:
albumin (ALB)
non-small cell lung (NSCLC)
prognostic biomarker
systemic anticancer therapy
targeted therapies
immunotherapies
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2021.734735/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2021.734735/full

Similar Items